Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 1
1964 1
1965 2
1967 1
1970 1
1972 1
1973 2
1975 2
1977 3
1979 2
1980 1
1981 4
1982 6
1983 3
1984 2
1985 4
1986 4
1987 3
1989 7
1990 6
1991 8
1992 5
1993 7
1994 5
1995 7
1996 2
1997 6
1998 4
1999 17
2000 6
2001 11
2002 9
2003 7
2004 7
2005 14
2006 7
2007 5
2008 4
2009 10
2010 9
2011 8
2012 3
2013 14
2014 8
2015 13
2016 19
2017 15
2018 20
2019 18
2020 11
2021 18
2022 3
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16825332

335 results
Results by year
Filters applied: . Clear all
Page 1
A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S. Storer TW, et al. J Clin Endocrinol Metab. 2005 Aug;90(8):4474-82. doi: 10.1210/jc.2005-0275. Epub 2005 May 24. J Clin Endocrinol Metab. 2005. PMID: 15914526 Clinical Trial.
Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS; AIDS Clinical Trials Group 329 Study Team; National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group. Mulligan K, et al. Arch Intern Med. 2005 Mar 14;165(5):578-85. doi: 10.1001/archinte.165.5.578. Arch Intern Med. 2005. PMID: 15767536 Clinical Trial.
335 results